Market Overview
The global anti-snoring devices and snoring surgery market was valued at USD 1.2 billion in 2024 and is expected to grow at a CAGR of 6.20% from 2025 to 2034. Growth is driven by increasing awareness of sleep disorders and associated health risks.
Snoring is a prevalent condition, often associated with obstructive sleep apnea (OSA) and other upper airway issues. It impacts not only individual health but also quality of life for bed partners, leading to increased demand for effective treatments. Anti-snoring solutions include oral appliances, positional therapy devices, nasal dilators, and surgical interventions. Oral appliances, such as mandibular advancement devices (MADs) and tongue-stabilizing devices, are widely used due to their convenience and effectiveness. Surgical options and implantable neurostimulation devices cater to patients who are intolerant of non-invasive devices or require long-term interventions.
Key Market Growth Drivers
- Increasing awareness and diagnosis of sleep disorders: Growing recognition of the health risks associated with snoring and OSA has led to expanded screening programs and higher diagnosis rates, fueling demand for both devices and surgeries.
- Preference for non-CPAP alternatives: Many patients find continuous positive airway pressure (CPAP) devices uncomfortable. This has shifted demand toward oral appliances, positional therapy devices, and implantable solutions.
- Technological advancements: Innovations such as custom-fitted oral appliances, connected devices for adherence monitoring, and minimally invasive surgical techniques are enhancing treatment effectiveness and patient compliance.
- Demographic factors: Rising obesity rates, an aging population, and increased cardiovascular risk are contributing to higher prevalence of snoring and sleep-disordered breathing, expanding the market base.
Key Market Challenges
- Variable reimbursement and access: Insurance coverage for anti-snoring devices and surgical procedures differs across regions, limiting accessibility for some patients.
- Patient adherence and clinical variability: Effectiveness of devices can vary depending on patient adherence and severity of snoring, which can affect market growth.
- High costs of surgical and implantable solutions: Surgical interventions and implantable neurostimulation therapies are expensive and carry procedural risks, limiting adoption in cost-sensitive regions.
- Regulatory and procedural complexity: Strict regulatory requirements and the need for specialized clinical training for surgeries can slow market penetration.
Regional Analysis
- North America: Leading the market due to advanced healthcare infrastructure, high awareness of sleep disorders, and established clinical pathways. Non-invasive devices and surgical interventions are both widely adopted.
- Europe: Demonstrates steady growth driven by favorable clinical guidelines, expanding diagnostic services, and a growing emphasis on patient-friendly therapies.
- Asia-Pacific: A high-growth region fueled by urbanization, rising obesity rates, and increasing healthcare expenditure. Affordability considerations favor non-invasive devices.
- Rest of the World (Latin America, Middle East & Africa): Emerging markets with increasing awareness of sleep disorders and gradual expansion of healthcare services present new growth opportunities.
Some of the major players operating in the global market include:
- Airway Management, Inc.
- Apnea Sciences Corp.
- Fisher & Paykel Healthcare Corp. Ltd.
- Koninklijke Philips NV
- MEDiTAS Ltd.
- ResMed Inc.
- Sleep Well Enjoy Life, Ltd.
- SomnoMed Ltd.
- Tomed Dr. Toussaint GmbH
Browse Full Insights:
Market Opportunities
- Integrated care pathways: Linking sleep specialists, dental professionals, and surgical providers can improve patient selection and outcomes.
- Digital and connected solutions: Monitoring tools and adherence tracking for oral appliances can enhance effectiveness and market appeal.
- Minimally invasive surgical innovations: New techniques that reduce recovery time and procedural risk will expand the eligible patient population.
- Awareness campaigns: Education about the health consequences of snoring and OSA can drive earlier diagnosis and treatment adoption.
Conclusion
The Anti-Snoring Devices and Snoring Surgery market is positioned for continued growth, driven by rising diagnosis rates, patient preference for comfortable therapies, and ongoing technological innovation. The market is evolving toward integrated, patient-centric solutions that emphasize adherence, personalization, and measurable clinical outcomes. Stakeholders who focus on improving accessibility, reducing costs, and enhancing patient satisfaction will be best positioned to capture market opportunities in the coming years.
More Trending Latest Reports By Polaris Market Research:
Drinking Water Adsorbents Market
Bake Your Favorite Desserts with Whipping Cream Powder Market
Tissue engineering and biomaterial-based regenerative medicine market
Protein A, G, and L Resins Market
